EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm
Portfolio Pulse from
The Schall Law Firm is urging investors to join a class action lawsuit against ESSA Pharma Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934. Investors who bought shares between December 12, 2023, and October 31, 2024, should contact the firm by March 25, 2025.
March 19, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ESSA Pharma Inc. is facing a class action lawsuit for alleged securities fraud, potentially impacting its stock price. Investors who purchased shares during the specified period are encouraged to join the lawsuit.
The lawsuit against ESSA Pharma Inc. for alleged securities fraud could negatively impact investor sentiment and the stock price. Legal issues often lead to uncertainty and potential financial liabilities, which can drive the stock price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100